Qiagen Under Fire Over QuantiFERON Guidance Reversal; Securities Investigation Underway
Schall Law Firm investigates Qiagen for alleged securities fraud over QuantiFERON guidance collapse—February projections of 6-7% growth reversed to flat in April.
QGENsecurities fraudclass action lawsuit